Enmein-type ent-kaurane diterpenoid spliced nitrogen mustard derivatives and preparation method and application thereof

A technology of santamicin and its derivatives, which is applied in the field of natural medicine and medicinal chemistry, can solve the problems of high toxicity and side effects, unsatisfactory therapeutic effect, lack of specificity of cell action, etc., and achieve the effect of good pharmaceutical activity

Active Publication Date: 2018-07-13
SHENYANG PHARMA UNIVERSITY
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This type of drug is widely used clinically, but its toxic and side effects are relatively large, and it lacks specificity for cell action, and with the occurrence of tumor drug resistance in recent years, the therapeutic effect is not satisfactory. Chemical modification, improving its curative effect has very important value

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enmein-type ent-kaurane diterpenoid spliced nitrogen mustard derivatives and preparation method and application thereof
  • Enmein-type ent-kaurane diterpenoid spliced nitrogen mustard derivatives and preparation method and application thereof
  • Enmein-type ent-kaurane diterpenoid spliced nitrogen mustard derivatives and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022]

[0023] Take sliverin-type core 2 (55mg, 0.15mmol), dissolve it in dichloromethane (5ml), add chlorambucil (92mg, 0.30mmol), EDCI (89mg, 0.46mmol), DMAP (8mg ,0.07mmol), the reaction was stirred at room temperature, the progress of the reaction was monitored by TCL, and the reaction was terminated after 24h. The reaction solution was poured into 20ml of ice-water mixture, extracted with dichloromethane (30ml×3), washed with saturated saline solution, dried over anhydrous sodium sulfate, and recovered dichloromethane to obtain crude product 6, which was passed through a silica gel column (dichloromethane: Methanol=200:1), separated to obtain a brown oil with a yield of 19%. HR-MS(ESI,M+H)m / z calcd for C 34 h 43 Cl 2 NO 7 :648.2458,found:648.2489. 1 H NMR (CDCl 3 ,400M Hz),δ(ppm):7.04,6.62(each 2H,d,J=8.4Hz,Ar-H),6.20(1H,s,14-CH),5.72(1H,s,6-CH) ,5.55(1H,s,17-CH 2 ),5.33(1H,s,17-CH 2 ), 4.57 (1H, dd, J = 11.5, 5.8Hz, 1-CH), 4.05, 3.93 (each 1H, d, J = 9.4Hz, ...

Embodiment 2

[0025]

[0026] Compound 7 was prepared according to the synthesis method of Example 1. White powder, yield 11%. HR-MS(ESI,M+H)m / z: calcd for C 31 h 37 Cl 2 NO 7 :628.1947,found:628.1968. 1 H NMR (CDCl 3 ,400M Hz), δ(ppm):7.87,6.62(each 2H,d,J A =J B =8.8Hz, Ar-H), 6.24(1H, s, 14-CH), 5.85(1H, s, 6-CH), 5.56(1H, s, 17-CH 2 ),5.36(1H,s,17-CH 2 ),4.57(1H,dd,J=11.5,5.8Hz,1-CH),4.01,4.11(each1H,d,J=9.4Hz,20-CH 2 ),3.64,3.79(each 4H,t,J=7.0Hz,8',9'-CH 2 ,10',11'-CH 2 ), 3.32(1H,d,J=9.4Hz,13-CH),1.05(3H,s,18-CH 3 ),0.98(3H,s,19-CH 3 ). 13 C NMR (CDCl 3 ,100MHz), δ(ppm):198.49,166.56,165.56,150.10,147.94,132.35(×2),120.13,117.64,110.91(×2),101.77,77.22,76.84,76.09,74.61,73.97,630.84 , 53.32, 50.17, 48.53, 41.00, 40.08, 37.10, 32.90, 31.03, 29.64, 23.29, 23.05, 19.79.

Embodiment 3

[0028]

[0029] Compound 8 was prepared according to the synthesis method of Example 1. Yellow oil, yield 25.6%. HR-MS(ESI,M+H)m / z: calcd for C 34 h 41 Cl 2 NO 7 :646.2351,found:646.2333. 1 H NMR (CDCl 3,400M Hz), δ(ppm)8.12(1H,dd,J=7.8,1.0Hz,Ar-H),7.60(1H,d,J=7.8Hz,Ar-H),7.47(1H,m,Ar -H),7.42(1H,d,J=8.2Hz,Ar-H),7.29(1H,m,Ar-H),7.22(1H,m,Ar-H),7.19(1H,m,Ar-H) H),7.16(1H,m,Ar-H),7.07(2H,d,J=8.5Hz,Ar-H),6.64(2H,d,J=8.5Hz,Ar-H),5.99(1H, s,NCH),3.99-4.90(6H,m,-CH 2 ),3.69(4H,m,NCH 2 CH 2 Cl),3.61(4H,m,NCH 2 CH 2 Cl),2.45-3.18(8H,m,-CH 2 ),2.40(3H,s,NCH 3 ),1.74-2.31(8H,m,-CH 2 ); 13 C NMR (CDCl 3 ,100M Hz)δ(ppm)173.62,164.72,151.07,144.25,137.40,132.97,131.05,129.85(×2),129.04,128.67,125.84,124.23,124.19,123.16,122.72,119.71,119.09,113.22,112.53( ×2),109.93,68.00,67.69,67.44,61.52,53.85(×2),40.72,40.53(×2),39.44,36.44,34.15,33.76,30.34,29.12,26.90,20.52.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of medicines, and relates to enmein-type ent-kaurane diterpenoid spliced nitrogen mustard derivatives and a preparation method and application thereof, inparticular to 14-OH spliced nitrogen mustard derivatives of enmein-type ent-kaurane diterpenoid, and a preparation method thereof and application thereof to preparation of anti-tumor medicines. The enmein-type ent-kaurane diterpenoid spliced nitrogen mustard derivatives and pharmaceutically acceptable salts thereof adopt a structural general formula I or II, wherein n is described in claims and adescription.

Description

technical field [0001] The invention relates to the fields of natural medicine and medicinal chemistry, in particular to a 14-OH compound nitrogen mustard derivative of a mesamicin-type diterpene. It specifically relates to the derivatives of these 14-OH mosaic DNA alkylating agent nitrogen mustard compounds in the sliverin-type diterpene, their preparation method and their application in the preparation of antitumor drugs. Background technique [0002] In 1958, Takshashi et al. obtained enmein from Rabdosia japonica for the first time. In 1966, Natsume et al. determined the three-dimensional structure of enmein by X-ray diffraction. compounds were isolated. Enmein is a natural organic compound of ent-kaurane diterpenoid isolated from the Labiatae genus Rabdosia, which has anti-cell proliferation and inhibits cancer cells. Synthesis of DNA, RNA and protein, induction of apoptosis, anti-mutation and β-receptor blockade, etc. Over the past 30 years, with the in-depth resear...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D493/10A61K31/37A61P35/00
CPCC07D493/10
Inventor 李达翃华会明李占林高祥吕昊达焦润伟王茗莹
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap